Oct 13, 2020

Proceedings from the second in a 3-part webinar series. Featuring perspectives from Drs Alexander E Drilon, Andrew McKenzie and Milan Radovich, including on the following topics:

• Part 1: Case Presentations
• • Introduction (00:00)
  • Case: A woman in her early 70s with metastatic adenocarcinoma of the lung (ERBB2, PALB2) — Milan Radovich, PhD (2:50)
  • Case: A man in his mid-70s with metastatic adenocarcinoma of the lung (BRAF V600E) — Andrew McKenzie, PhD (8:55)
  • Case: A woman in her mid-70s with metastatic NSCLC (EGFR exon 19 insertion) — Sulfi Ibrahim, MD (12:38)
  • Case: A man in his mid-60s with recurrent SCCHN (TMB 215 mut/Mb) — Dr Radovich (16:52)
  • Case: A man in his early 60s with metastatic adenocarcinoma of the lung (STK11, BRCA) — Dr Ibrahim (20:55)
  • Case: A woman in her early 30s with metastatic adenocarcinoma of the lung (EML4-RET fusion) — Alexander E Drilon, MD (25:52)
• Part 2: Beyond EGFR, BRAF and ALK — Actionable Biomarkers in NSCLC
• • Faculty Presentation — Dr Drilon (27:49)
• Part 3: Case Presentations
• • Case: A woman in her mid-60s with metastatic adenocarcinoma of the lung (RET fusion) — Dr McKenzie (40:15)
  • Case: A man in his late 50s with metastatic adenocarcinoma of the lung (RET fusion) — Dr Ibrahim (44:59)
  • Case: A man in his late 60s with metastatic pancreatic cancer (ERC1/RET fusion) — Dr Radovich (48:02)
  • Case: A woman in her mid-70s with metastatic adenocarcinoma of the lung (EPS15-NTRK1) — Dr Drilon (50:28)
  • Case: A man in his early 80s with metastatic adenocarcinoma of the lung (MET exon 14) — Dr McKenzie (52:14)
  • Case: A woman in her mid-80s with Stage IIIB NSCLC (MET exon 14 skipping mutation) — Dr Ibrahim (55:43)
  • Case: A man in his early 70s with metastatic NSCLC (MET exon 14 splice site mutation) — Dr Radovich (58:41)

CME information and select publications